![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, August 02, 2021 12:31:56 AM
Summation of DD:
The DOJ action was not seen as material to disclose outside of the 10K. Arian Colachis said, no one in the company is shorting the stock.
Paul Rosenscam resides in Oregon.
What seems to be orchestrated hit pieces from (PAUL) Oregon:
July 30th (date of 10K to promote FUD):
Lies about what the FDA SAID: “statistically insignificant”
What the 10K actually said:
“In closing, FDA stated that subgroup analyses may inform the design of future clinical trials investigating leronlimab for the treatment of COVID-19.”
“Preliminary results from the trial suggested leronlimab improved a majority of clinical symptoms with a Top-line Report expected to be issued AFTER this filing.”
Proxy:
Board meeting can be postponed and will be if they need to. But
the confidence of CytoDyns 8K tells ME something BIG is coming.
I don’t think there will even be a proxy vote. Key words from 10K: “potential proxy”
Furthermore:
The same Oregon article above actually linked the May 18th hit piece about The FDA statement. Why would someone who wants to accelerate LL pay for that article?
My question is why do these hit pieces all revolve around things that could be manipulated or influenced? Didn’t the 13D crew insinuate or say they had friends in the FDA?
Phantom Lawsuits:
IncellDx is near GILD world head quarters. Those law firms are around 13Ds residencies or even around 13Ds proxy consultants.
Competition doesn’t concern me:
“Maraviroc, like all other HIV approved drugs, must be taken daily and is believed to have side effects and toxicity.”
The CytoDyn -Jonah Sacha- formula for 1-3 month treatment seems to be going well.
What stood out to me for RO Assay was this:
“Importantly, and in parallel with the submission of our pivotal trial protocol for monotherapy, we recently announced the completion of the development of >>A<< receptor occupancy assay to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab.
Provisions:
“provisions could prevent or frustrate attempts by our stockholders to replace or remove members of our Board.”
Cash:
They focus on cash at hand (35M).
but not that our CRO is PREPAID, and that our trials overseas are cost effective. A faster enrollment bonus of (younger) and (likely) high CCR5 expressive patients are going to be expedited for 40% interim analysis.
SEC is done:
“The SEC has informed the Company that this inquiry should not be construed as an indication that any violations of law have occurred or that the SEC has any negative opinion of any person, entity or securities trading activity.”
Coming soon:
LH topline and Brazil trials.
Insider buying in August window is open.
Possible Cancer and NASH BTD.
Personally, I can’t ever vote for Paul when he sexually harassed a female and then wants control over MTNBC.
I can’t vote for Dr. Burglar Pattent for taking IP under NDA and withholding data.
I can’t vote for The group when Beaty / Errico collectively dump on positive Press Releases. Or when Beaty bought several 10K lots around the time “TI” on YMB claimed were all institutional buys, and suddenly TI supports 13D and Beaty later dumps during the Citron article hit piece.
To end this positively: have you read the LH article CytoDyn posted?
The trials involving LH include
“stretching and massage” “probiotics” “melatonin”
It’s all about il6; gut and inflammation,and we know that t-cells are “potentially” blocked from forming inflammation and patients slept better.
I hypothesize (not a doctor or scientist) that the Diarrhea SE for some patients is actually cleaning out the patient similar to a hydro therapy colon cleanse. With less “SIBO” (small intestinal Bacteria Overgrowth) the body will function better.
What I believe happening to the body is Carbs (for LH sufferers) are not turning into ATP, rather they’re staying in the pyruvate state and turning into what we know as “Lactic Acid” (Lactate). Unfortunately, when we eat, the SIBO is eating our nutrients and we get weaker, causing inflammation, ammonia (causing fog brain) etc.
With high levels of Lactic Acid comes “High anion gap metabolic acidosis (HAGMA)” it ultimately causes Hypoxia (lack of O2 in body) resulting in possible, Sepsis, multiple Organ Failure, shock, CHF, diabetes, and LIVER disease.
Once Recknor finds specific details on MOA of LL, I believe he uncovers everything inflammatory related.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM